MoneyWorks4Me

Samrat Pharmachem informs about issuance of duplicate share certificates

24 Jul 2023 Evaluate

Samrat Pharmachem has informed that it enclosed the intimation letter dated July 14, 2023, received from its Registrar and Share Transfer Agent, Link Intime India, providing information regarding issue of duplicate share certificates to the shareholder(s) of the Company. The information is being submitted pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..